Login / Signup

Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study.

Deborah F NacerJohan Vallon-ChristerssonNicklas NordborgHans EhrencronaAnders KvistÅke BorgJohan Staaf
Published in: Genome medicine (2023)
The Sweden Cancerome Analysis Network - Breast (SCAN-B) was prospectively registered at ClinicalTrials.gov under the identifier NCT02306096.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • computed tomography
  • newly diagnosed
  • magnetic resonance
  • oxidative stress
  • magnetic resonance imaging
  • dna damage
  • patient reported
  • contrast enhanced